QSimulate and Japan Tobacco Inc. (JT) announced a strategic partnership in the development of small molecule drug discovery technology.
Sep. 3, 2024
- News
Quantum Simulation Technologies, Inc. (Head Office: Boston, USA; CEO: Toru Shiozaki; refer as ‘QSimulate’ onwards;) and Japan Tobacco Inc. (Head Office: Minato-ku, Tokyo; President & CEO: Masamichi Terahata; refer as ‘JT’ onwards;) announced the conclusion of a strategic partnership to develop AI drug discovery technology.
Through this strategic partnership, QSimulate will provide its cutting-edge simulation technology for the development of JT’s proprietary AI drug discovery technology. This will enable JT to further accelerate the advancement of advanced drug discovery technologies and deliver breakthrough original drugs to patients more rapidly.
For more information, click on the link below.